Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaps in lipid management after diabetes diagnosis and associated cardiovascular outcomes in a cohort of US adults.

medRxiv : the preprint server for health sciences·2026
Same author

Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations.

Nature genetics·2026
Same author

X-Chromosome-Wide Association Study Identifies Novel Genetic Signals for Heart Failure and Subtypes.

medRxiv : the preprint server for health sciences·2026
Same author

Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes: a prospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Dietary sodium and potassium intake and risk of diabetes in the Million Veteran Program.

Clinical nutrition ESPEN·2026
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity: why be concerned?

W Virgil Brown1, Ken Fujioka, Peter W F Wilson

  • 1Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia 30033, USA. W.Virgil.Brown@med.va.gov

The American Journal of Medicine
|May 5, 2009
PubMed
Summary
This summary is machine-generated.

The US obesity epidemic is a major public health crisis linked to numerous diseases and early mortality. Increased awareness is needed to prioritize weight management and allocate healthcare resources effectively.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Localization, Identification, and Excision of Murine Adipose Depots
08:53

Localization, Identification, and Excision of Murine Adipose Depots

Published on: December 4, 2014

Related Experiment Videos

Last Updated: Jun 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Localization, Identification, and Excision of Murine Adipose Depots
08:53

Localization, Identification, and Excision of Murine Adipose Depots

Published on: December 4, 2014

Area of Science:

  • Public Health
  • Epidemiology
  • Healthcare Management

Background:

  • The United States faces a significant obesity epidemic, posing substantial public health challenges.
  • Excess body fat is associated with major health risks, including cardiovascular disease and diabetes mellitus.
  • Obesity contributes to a wide range of other health problems, increasing morbidity and mortality rates.

Purpose of the Study:

  • To underscore the critical nature of the obesity epidemic as a public health issue.
  • To advocate for public recognition of obesity beyond cosmetic or lifestyle concerns.
  • To promote increased awareness of health risks associated with excess weight to improve management strategies.

Main Methods:

  • This study is a review and synthesis of existing public health data and research on obesity.
  • Analysis of the epidemiological trends and associated healthcare costs of obesity in the US.
  • Literature review on the multifaceted health consequences of overweight and obesity.

Main Results:

  • Obesity represents a critical public health issue with significant potential for increased healthcare costs.
  • Beyond well-known risks like cardiovascular disease and diabetes, obesity is linked to numerous other health problems.
  • Lack of public recognition of obesity as a health crisis hinders effective prevention and management.

Conclusions:

  • Greater public and healthcare provider awareness of obesity's health risks is essential.
  • Enhanced recognition can lead to more frequent screenings and proactive weight management discussions.
  • Increased commitment of healthcare resources to obesity prevention and management is crucial for public health improvement.